FRIEDLI PETER 4
4 · OSIRIS THERAPEUTICS, INC. · Filed Mar 26, 2008
Insider Transaction Report
Form 4
FRIEDLI PETER
Director10% OwnerOther
Transactions
- Purchase
Convertible Promissory Note
2008-03-24$12.17/sh+2,500,000$30,425,000→ 1,205,423 totalExercise: $12.17From: 2008-03-25Exp: 2008-11-30→ Common Stock (205,423 underlying)
Footnotes (1)
- [F1]Convertible promissory note pursuant to a private placement intended to qualify under Regulation S of the Securities Act of 1933, as amended. The Note bears interest at the rate of 2% per annum, payable upon maturity on November 30, 2008. The Note is convertible at any time at the sole discretion of the holder into shares of the Company's common stock at the conversion price of $12.17 per share, and redeemable by the Company with 30-days prior notice. The Note affords the holder registration rights in respect of any shares issued uon conversion